Heterogeneity of the resistance to gefitinib treatment in a non‐small cell lung cancer patient with active epidermal growth factor receptor mutation

Por Xu, Chong‐Rui, Zhong, Wen‐Zhao, Zhou, Qing, Zhang, Xu‐Chao, Yang, Jin‐Ji, Wu, Yi‐Long
Publicado no Thorac Cancer (2016)

Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer

Por Wei, Xue‐Wu, Gao, Xin, Zhang, Xu‐Chao, Yang, Jin‐Ji, Chen, Zhi‐Hong, Wu, Yi‐Long, Zhou, Qing
Publicado no Thorac Cancer (2020)

Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib

Por Cheng, Hua, An, She-Juan, Dong, Song, Zhang, Yi-Fang, Zhang, Xu-Chao, Chen, Zhi-Hong, Jian-Su, Wu, Yi-Long
Publicado em 2011

Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC)

Por Yang, Xue-Ning, Huang, Ling, Chen, Yu, An, She-Juan, Zhang, Xu-Chao, Liao, Ri-Qiang, Su, Jian, Wu, Yi-Long
Publicado no Chin J Cancer Res (2015)

Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform

Por Tian, Hong-Xia, Zhang, Xu-Chao, Wang, Zhen, Chen, Jian-Guang, Chen, Shi-Liang, Guo, Wei-Bang, Wu, Yi-Long
Publicado no Cancer Biol Med (2016)

Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer

Por Tian, Hong-Xia, Zhang, Xu-Chao, Wang, Zhen, Yang, Jin-Ji, Guo, Wei-Bang, Chen, Zhi-Hong, Wu, Yi-Long
Publicado no Chin Med J (Engl) (2017)

Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases

Por Li, Yang-Si, Zheng, Mei-Mei, Jiang, Ben-Yuan, Tu, Hai-Yan, Yang, Jin-Ji, Zhang, Xu-Chao, Wu, Yi-Long
Publicado no JAMA Netw Open (2020)

Responses to crizotinib in a patient with c-ros oncogene 1, receptor tyrosine kinase-positive advanced lung adenocarcinoma: A case report

Por ZHANG, NA, YANG, JIN-JI, ZHANG, XU-CHAO, XIE, ZHI, WANG, BIN-CHAO, TU, HAI-YAN, JIANG, BEN-YUAN, WU, YI-LONG
Publicado em 2014

The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma

Por Zhang, Na, Jiang, Ben-Yuan, Zhang, Xu-Chao, Xie, Zhi, Su, Jian, Zhang, Qi, Han, Jie-Fei, Tu, Hai-Yan, Wu, Yi-Long
Publicado no J Thorac Dis (2015)

Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer

Por Chen, Hua-Jun, Yang, Jin-Ji, Fang, Liang-Yi, Huang, Min-Min, Yan, Hong-Hong, Zhang, Xu-Chao, Xu, Chong-Rui, Wu, Yi-Long
Publicado no Thorac Cancer (2014)

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines

Por Bai, Xiao-Yan, Zhang, Xu-Chao, Yang, Su-Qing, An, She-Juan, Chen, Zhi-Hong, Su, Jian, Xie, Zhi, Gou, Lan-Ying, Wu, Yi-Long
Publicado no PLoS One (2016)

RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

Por Dong, Song, Guo, Ai-Lin, Chen, Zhi-Hong, Wang, Zhen, Zhang, Xu-Chao, Huang, Ying, Xie, Zhi, Yan, Hong-Hong, Cheng, Hua, Wu, Yi-Long
Publicado em 2010

Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells

Por Fei, Shi-Jiang, Zhang, Xu-Chao, Dong, Song, Cheng, Hua, Zhang, Yi-Fang, Huang, Ling, Zhou, Hai-Yu, Xie, Zhi, Chen, Zhi-Hong, Wu, Yi-Long
Publicado em 2013

Familial association of lung cancer with liver cancer in first-degree relatives

Por Xu, Chong-Rui, Lin, Huan, Su, Jian, Zhang, Xu-Chao, Huang, Yi-Sheng, Yang, Xue-Ning, Zhou, Qing, Yang, Jin-Ji, Zhong, Wen-Zhao, Wu, Yi-Long
Publicado no Cancer Manag Res (2019)

Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer

Por Gao, Hong-Fei, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Guo, Wei-Bang, Zhou, Qing, Gou, Lou-Ying, Dong, Zhong-Yi, Wu, Yi-Long
Publicado no Oncotarget (2016)

Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay

Por Su, Jian, Zhang, Xu-Chao, An, She-Juan, Zhong, Wen-Zhao, Huang, Ying, Chen, Shi-Liang, Yan, Hong-Hong, Chen, Zhi-Hong, Guo, Wei-Bang, Huang, Xiao-Sui, Wu, Yi-Long
Publicado em 2014

Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer

Por AN, SHE-JUAN, LIN, QIU-XIONG, CHEN, ZHI-HONG, SU, JIAN, CHENG, HUA, XIE, ZHI, ZHANG, XU-CHAO, ZHOU, HAI-YU, HUANG, YING, CHEN, SHI-LIANG, GUO, WEI-BANG, WU, YI-LONG
Publicado em 2012

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer

Por Peng, Xiao-Xiao, Yu, Ruoying, Wu, Xue, Wu, Shu-Yu, Pi, Can, Chen, Zhi-Hong, Zhang, Xu-Chao, Gao, Cun-Yi, Shao, Yang W, Liu, Li, Wu, Yi-Long, Zhou, Qing
Publicado no J Immunother Cancer (2020)

BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification

Por Jiang, Ben-yuan, Zhang, Xu-chao, Su, Jian, Meng, Wei, Yang, Xue-ning, Yang, Jin-ji, Zhou, Qing, Chen, Zhi-yong, Chen, Zhi-hong, Xie, Zhi, Chen, Shi-liang, Wu, Yi-long
Publicado em 2013

Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma‐like carcinoma

Por Yin, Kai, Feng, Hui‐Bo, Li, Lin‐Lin, Chen, Yu, Xie, Zhi, Lv, Zhi‐Yi, Guo, Wei‐Bang, Lu, Dan‐Xia, Yang, Xue‐Ning, Yan, Wen‐Qing, Wu, Yi‐Long, Zhang, Xu‐Chao
Publicado no Thorac Cancer (2019)